Location permission needed for a better experience.
How can we help you?
CV
MEMBERSHIPS
PUBLICATIONS
EDUCATION
  • 2009 Marmara Üniversitesi Tıp Fakültesi Tıbbi Onkoloji
  • 2003 Haydarpaşa Numune Eğitim ve Araştırma Hastanesi İç Hastalıkları
  • 1994 Ankara Üniversitesi Tıp Fakültesi
EXPERIENCE
  • 2010 Trabzon Numune Eğitim ve Araştırma Hastanesi / Tıbbi Onkoloji Uzmanı
  • 2009 - 2010 Erzurum Bölge Eğitim ve Araştırma Hastanesi / Tıbbi Onkoloji Uzmanı
  • 2005 - 2009 Marmara Üniversitesi Tıp Fakültesi / Yan Dal Uzmanlık Eğitimi
  • 2003 - 2005 Haydarpaşa Numune Eğitim ve Araştırma Hastanesi / İç Hastalıkları Uzmanı
  • 2004 Acıbadem Sağlık Grubu
  • 1998 - 2003 Haydarpaşa Numune Eğitim ve Araştırma Hastanesi / İç Hastalıkları Asistanı
  • 1996 - 1998 Trabzon Merkez Çağlayan Sağlık Ocağı / Pratisyen Hekim
  • 1994 - 1996 Trabzon Düzköy İlçesi Aykut Beldesi Sağlık Ocağı / Pratisyen Hekim
MEMBERSHIPS
  • Tıbbi Onkoloji Derneği
  • Türk Tabipler Birliği
PUBLICATIONS
  • Pregnancy a short time after multimodal therapy for bilateral breast cancer: a case report and review of literature J Oncol Pharm Pract September 21, 20101078155210384755 Timur Koca Zuleyha Akgun zuleyh@hotmail.com Serap Baskaya Yucel Nihal Zerman Dag Mehmet Teomete
  • Weight gain after adjuvant chemotherapy in patients with early breast cancer in Istanbul Turkey Medical Oncology 001: 10.1007js12032-010-9463-x Gul Basaran, Nazlm Serdar Turhal, Devrim Cabukr Nevin Yurt, Gul Yurtseven, Mahmut Gumus, Mehmet Teomete, Faysal Dane and Perran Fulden Yumuk
  • 0utcome of metastatic colorectal cancer patients receiving second line chemotherapy in Marmara University Hospital F. Dane, M. Gumus, A. Ozturk, F. Yumuk, S. Iyikesici, G. Basaran, D. Cabuk, M. Teomete and N. S. Turhal 18S (June 20 Supplement), 2007: 14588© 2007 American Society of Clinical Oncology Journal of Clinical Oncology, 2007 ASCO Annual Meeting Proceedings (Post-Meeting Edition). Vol 25, No
  • Impact of dose reductions of platinum compounds on survival in stage IIIB/IV non-small cell lung cancer (NSCLC) P. F. Yumuk, M. Teomete, F. Dane, D. Cabuk, G. Basaran and N. S. Turhal Marmara University Medical School Hospital, Istanbul, Turkey 15S (May 20 Supplement), 2009: e19055© 2009 American Society of Clinical Oncology Journal of Clinical Oncology, 2009 ASCO Annual Meeting Proceedings (Post-Meeting Edition). Vol 27, No
  • Pulmonary toxicity in patients receiving docetaxel chemotherapy U. Kefeli, P. F. Yumuk, B. Ceyhan, F. Dane, B. Eroglu, D. Cabuk, G. Basaran, M. Teomete and N. S. Turhal. No 15S (May 20 Supplement), 2009: e13532© 2009 American Society of Clinical Oncology Journal of Clinical Oncology, 2009 ASCO Annual Meeting Proceedings (Post-Meeting Edition). Vol 27,
  • Benefit from adjuvant anthracyclines according to hormone receptor status G. Atalay Basaran, D. Cabuk, M. Teomete, B. Gulluoglu, H. Kaya, F. Dane, P. F. Yumuk and N. S. Turhal Vol 26, No 15S (May 20 Supplement), 2008: 11513© 2008 American Society of Clinical Oncology Marmara University Hospital, Istanbul, Turkey Journal of Clinical Oncology, 2008 ASCO Annual Meeting Proceedings (Post-Meeting Edition).
  • The relationship between glycemic control and platelet activity in type 2 diabetes mellitus Received 24 May 2007; received in revised form 7 January 2008; accepted 18 January 2008. published online 25 March 2008. Refik Demirtunc, Dursun Duman, Melih Basar, Mustafa Bilgi, Mehmet Teomete, Tayfun Garip
  • A case of Kikuchi-Fujimoto disease misdiagnosed as Hodgkin''s lymphoma: the importance of second opinion. J aVON. 2009 Apr-Jun;14(2):309-11 Dane F, Ozturk MA, Tecimer T, Atasoy BM, Cabuk D, Yumuk PF, Basaran G, Teomete M, Turhal NS.
  • Clinical outcome of triple-negative (TN) breast cancer (BC) D. Cabuk, G. Basaran, H. Kaya, B. Gulluoglu, M. Teomete, F. Dane, P. F. Yumuk and N. S. Turhal (Post-Meeting Edition). Vol 26, No 15S (May 20 Supplement), 2008: 11526 © 2008 American Society of Clinical Oncology MUTFH, Istanbul, Turkey Journal of Clinical Oncology, 2008 ASCO Annual Meeting Proceedings
  • Clinical features and outcome of adjuvant chemoradiotherapy in Turkish rectal carcinoma patients: Single institution experience F. Dane, M. Gumus, M. A. Ozturk, D. Cabuk, M. B. Atasoy, P. F. Yumuk, G. Basaran, M. S. Iyikesici, M. Teomete, U. Abacioglu and N. S. Turhal Journal of Clinical Oncology, 2008 ASCO Annual Meeting Proceedings (Post-Meeting Edition). Marmara University Medical Oncology, Istanbul, Turkey; Marmara University Radiation Oncology, Istanbul, Turkey
  • Clinical outcome of node-negative (NN) breast cancer (BC) patients Marmara University Hospital, Istanbul, Turkey Journal of Clinical Oncology, 2007 ASCO Annual Meeting Proceedings (Post-Meeting Edition). G. Atalay Basaran, D. Cabuk, F. Dane, M. Teomete, S. Iyikesici, E. Meltem, B. Gulluoglu, H. Kaya, U. AbaCloglu, F. Yumuk and S. Turhal
  • 0utcome of patients with stage III and IV non-small cell lung cancer in Marmara University Hospital, Istanbul, Turkey Journal of Thoracic Oncology: August 2007 - Volume 2 - Issue 8 - p S701 doi: 10.1 097jOl.JTO. 0000284031.87598.62 Yumuk, Perran F.; Teomete, Mehmet; Dane, Faysal; Cabuk, Devrim; Caglar, Hale B.; Abacioglu, Ufuk; Basaran, Gul; Turhal, Nazim S.

INFORMATION FORM WITH REGARD TO OBTAINING AND PROCESSING OF PERSONAL DATA

Acıbadem Sağlık Hizmetleri ve Ticaret A.Ş. (“Acıbadem”) and Acıbadem’s controlling shareholders, parent companies and affiliates (hereinafter to be collectively referred to as “Acıbadem Group”) may, acting as “Data Supervisor” under the Law on Protection of Personal Data no. 6698 (the “Law”) and other pertinent laws and regulations, process your personal data within the following frame and in strict compliance with the Basic Healthcare Services Law no. 3359, the Governmental Decree-Law on Organization and Duties of the Ministry of Health and its Affiliated Companies no. 663, the Private Hospitals Regulation, and other regulations of the Ministry of Health, and other applicable laws and provisions.

1. Obtaining and Processing of Personal Data, and Purposes of Processing:

Your personal data is collected and obtained verbally, in writing, or in visual or electronic media, through call center, internet site, verbally, in writing or similar other channels for conduct of such services as protection of public health, preventive medicine, medical diagnosis, treatment and maintenance services offered by Acıbadem Group, or for planning and management of healthcare services and financing, and in accordance with the fields of business of Acıbadem Group Companies. Your general personal data and special personal data, especially your healthcare data, may be processed by the Group to a limited extent for all and any purposes, including, but not limited to, the following purposes:

All kinds of your personal data obtained by Acıbadem Group (including, but not limited to, your special personal data) may be processed for the following purposes:

Your personal data obtained and processed pursuant to the applicable laws and regulations may be transferred to physical archives and/or information systems of Acıbadem or Acıbadem Group and may be kept and stored both in digital and in physical platforms.

2. Transfer of Personal Data

Your personal data may be shared by Acıbadem and Acıbadem Group with companies included in Acıbadem Group or with private insurance companies, Ministry of Health and its sub-units, Social Security Agency, Security General Directorate and other security forces, General Directorate of Population and Census, Turkish Pharmacists’ Association, courts and all kinds of other juridical authorities, central etc. third parties, your authorized representatives and agents, and third parties offering consulting and advice services to us, including, but not limited to, lawyers, tax and financial consultants and auditors, and our business partners and other third parties acting in cooperation with us for further development or performance of healthcare services for the purposes cited above, also including regulatory and supervisory bodies and authorities, and official authorities, for the purposes of processing listed above, in accordance with the Law and other applicable laws and regulations.

3. Methods and Legal Causes of Obtaining of Personal Data

Your personal data are collected and processed in all kinds of verbal, written, visual or electronic media, for the purposes listed hereinabove, and for performance of all kinds of works included in the fields of business of Acıbadem within the legal framework, and accordingly, for full and proper performance of all kinds of contractual and legal duties and obligations of Acıbadem. Legal causes of collection and acquisition of your personal data are the pertinent provisions of:

Furthermore, as stipulated in 3rd paragraph of article 6 of the Law, personal data relating to health may also be processed by persons under secrecy obligations or by authorized official entities and organizations, without being liable to receive prior explicit consent of the relevant purpose, only for protection of public health, preventive medicine, medical diagnosis, treatment and maintenance services, and for planning and management of healthcare services and financing.

4. Your Rights Regarding Protection of Personal Data

Pursuant to the Law and other relevant applicable laws and regulations, you are entitled:

If at any time you use any one or more of your aforesaid rights, the relevant information will be transmitted to you clearly and in an understandable manner, in writing or in electronic media, by using the communication data and information provided by you.

5. Data Security

Acıbadem protects your personal data in full and strict compliance with all technical and administrative security controls required to be taken in accordance with information security standards and procedures. Said security actions and measures are taken and provided at a level appropriate for the probable risks by also taking into consideration the technological possibilities.

6. Complaints and Communications

Your personal data are protected within the frame of the available technical and administrative possibilities, and the required security actions and measures are taken and provided at a level appropriate for the probable risks by also taking into consideration the technological possibilities.

By filling in the “Application Form Pursuant to the Law on Protection of Personal Data” given at the , “https://www.acibadem.com.tr/acibademonline/hastaverilerinkorunmasi.html” web address, you may transmit and submit your legal requests:

You are hereby kindly requested to transmit your legal requests under the Law by filling in the “Application Form Pursuant to the Law on Protection of Personal Data” given at the https://www.acibadem.com.tr/acibademonline/hastaverilerinkorunmasi.html web address and sending it to us by the communication means set forth in the form.

TOP